Frieden TR, Myers JE, Krauskopf MS, Farley TA: A public health approach to winning the war against cancer. The oncologist. 2008, 13 (12): 1306-1313.
PubMed
Google Scholar
Grosso G, Biondi A, Marventano S, Mistretta A, Calabrese G, Basile F: Major postoperative complications and survival for colon cancer elderly patients. BMC surgery. 2012, 12 (Suppl 1): S20-
PubMed Central
PubMed
Google Scholar
Biondi A, Grosso G, Mistretta A, Marventano S, Toscano C, Gruttadauria S, Basile F: Laparoscopic-assisted versus open surgery for colorectal cancer: short- and long-term outcomes comparison. Journal of laparoendoscopic & advanced surgical techniques Part A. 2013, 23 (1): 1-7.
Google Scholar
Biondi A, Motta S, Di Giunta M, Crisafi RM, Zappala S, Rapisarda D, Basile F: [The use of laparoscopy for diagnosis and stadiation of the lymphomas]. Annali italiani di chirurgia. 2009, 80 (6): 445-447.
PubMed
Google Scholar
Biondi A, Tropea A, Basile F: Clinical rescue evaluation in laparoscopic surgery for hepatic metastases by colorectal cancer. Surgical laparoscopy, endoscopy & percutaneous techniques. 2010, 20 (2): 69-72.
Google Scholar
Biondi A, Tropea A, Monaco G, Musumeci N, Benfatto G, Basile F: [Management of early rectal cancer: our clinical experience]. Il Giornale di chirurgia. 2011, 32 (12): 34-36.
CAS
PubMed
Google Scholar
Vacante M, D'Agata V, Motta M, Malaguarnera G, Biondi A, Basile F, Malaguarnera M, Gagliano C, Drago F, Salamone S: Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems. BMC surgery. 2012, 12 (Suppl 1): S36-
PubMed Central
PubMed
Google Scholar
Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW: Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA: a cancer journal for clinicians. 2013, 63 (2): 88-105.
Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA: a cancer journal for clinicians. 2011, 61 (2): 69-90.
Google Scholar
Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, et al: Serrated lesions of the colorectum: review and recommendations from an expert panel. The American journal of gastroenterology. 2012, 107 (9): 1315-1329. quiz 1314, 1330
PubMed Central
PubMed
Google Scholar
Benfatto G, Biondi A, Di Stefano G, Basile G, Jiryis A, Strano G, Mugavero F, Cinardi N, Benfatto SM: Low rectal cancer treatment in frail elderly patients. A personal series. Il Giornale di chirurgia. 2007, 28 (5): 203-208.
CAS
PubMed
Google Scholar
Ragusa M, Statello L, Maugeri M, Majorana A, Barbagallo D, Salito L, Sammito M, Santonocito M, Angelica R, Cavallaro A, et al: Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors. J Mol Med (Berl). 2012, 90 (12): 1421-1438.
CAS
Google Scholar
Ragusa M, Majorana A, Statello L, Maugeri M, Salito L, Barbagallo D, Guglielmino MR, Duro LR, Angelica R, Caltabiano R, et al: Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment. Molecular cancer therapeutics. 2010, 9 (12): 3396-3409.
CAS
PubMed
Google Scholar
Norn S, Permin H, Kruse PR, Kruse E: From willow bark to acetylsalicylic acid. Dansk medicinhistorisk arbog. 2009, 37: 79-98.
PubMed
Google Scholar
Lanas A, McCarthy D, Voelker M, Brueckner A, Senn S, Baron JA: Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Drugs in R&D. 2011, 11 (3): 277-288.
Google Scholar
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, et al: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. The New England journal of medicine. 1983, 309 (7): 396-403.
PubMed
Google Scholar
Dube C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D: The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Annals of internal medicine. 2007, 146 (5): 365-375.
PubMed
Google Scholar
Macdonald S: Aspirin use to be banned in under 16 year olds. BMJ. 2002, 325 (7371): 988-
PubMed Central
PubMed
Google Scholar
Rigattieri S, Silvestri P, Minucci A, Di Russo C, Ferraiuolo G, Giardina B, Capoluongo E, Loschiavo P: Drug-eluting stents in a patient with favism: is the aspirin administration safe?. J Cardiovasc Med (Hagerstown). 2008, 9 (11): 1159-1162.
Google Scholar
Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011, 377 (9759): 31-41.
CAS
PubMed
Google Scholar
Thun MJ, Calle EE, Namboodiri MM, Flanders WD, Coates RJ, Byers T, Boffetta P, Garfinkel L, Heath CW: Risk factors for fatal colon cancer in a large prospective study. Journal of the National Cancer Institute. 1992, 84 (19): 1491-1500.
CAS
PubMed
Google Scholar
Neugut AI, Jacobson JS, De Vivo I: Epidemiology of colorectal adenomatous polyps. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1993, 2 (2): 159-176.
CAS
Google Scholar
Arber N: Do NSAIDs prevent colorectal cancer?. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2000, 14 (4): 299-307.
CAS
PubMed
Google Scholar
Thun MJ, Namboodiri MM, Heath CW: Aspirin use and reduced risk of fatal colon cancer. The New England journal of medicine. 1991, 325 (23): 1593-1596.
CAS
PubMed
Google Scholar
Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS: Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008, 134 (1): 21-28.
PubMed Central
CAS
PubMed
Google Scholar
Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS: Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA : the journal of the American Medical Association. 2005, 294 (8): 914-923.
CAS
PubMed
Google Scholar
Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, et al: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. The New England journal of medicine. 2003, 348 (10): 883-890.
CAS
PubMed
Google Scholar
Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, et al: A randomized trial of aspirin to prevent colorectal adenomas. The New England journal of medicine. 2003, 348 (10): 891-899.
CAS
PubMed
Google Scholar
Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR: Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology. 2008, 134 (1): 29-38.
CAS
PubMed
Google Scholar
Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S: Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 2003, 125 (2): 328-336.
CAS
PubMed
Google Scholar
Burn J, Bishop DT, Mecklin JP, Macrae F, Moslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, et al: Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. The New England journal of medicine. 2008, 359 (24): 2567-2578.
CAS
PubMed
Google Scholar
Burn J, Chapman PD, Bishop DT: Results of the CAPP1 study: aspirin and resistant starch are beneficial in familial adenomatous polyposis. Fam Cancer. 2003, 2: 42-45.
Google Scholar
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA : the journal of the American Medical Association. 2005, 294 (1): 47-55.
CAS
PubMed
Google Scholar
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH: Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Journal of the National Cancer Institute. 1993, 85: 1220-1224.
CAS
PubMed
Google Scholar
Farrell B, Godwin J, Richards S, Warlow C: The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. Journal of neurology, neurosurgery, and psychiatry. 1991, 54 (12): 1044-1054.
PubMed Central
CAS
PubMed
Google Scholar
Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al: Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed). 1988, 296 (6618): 313-316.
CAS
Google Scholar
Flossmann E, Rothwell PM: Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007, 369 (9573): 1603-1613.
CAS
PubMed
Google Scholar
Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, Logan RF, Rothwell PM, Schror K, Baron JA: Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila). 2012, 5 (2): 164-178.
CAS
Google Scholar
Patrono C, Patrignani P, Garcia Rodriguez LA: Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. The Journal of clinical investigation. 2001, 108 (1): 7-13.
PubMed Central
CAS
PubMed
Google Scholar
Gupta RA, DuBois RN: Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer. Annals of the New York Academy of Sciences. 2000, 910: 196-204. discussion 204-196
CAS
PubMed
Google Scholar
Dannenberg AJ, Zakim D: Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Seminars in oncology. 1999, 26 (5): 499-504.
CAS
PubMed
Google Scholar
Schror K: Acetylsalicyclic acid. 2009, Weinheim, Germany: WILEY-VCH Verlag GmbH & Co. KGaA
Google Scholar
Ruschoff J, Dietmaier W, Bocker T, Wallinger S, Kullmann F, Beham A, Hofstadter F: Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?. Der Pathologe. 1998, 19 (4): 269-278.
CAS
PubMed
Google Scholar
Babbar N, Gerner EW, Casero RA: Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. The Biochemical journal. 2006, 394 (Pt 1): 317-324.
PubMed Central
CAS
PubMed
Google Scholar
Martinez ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, et al: Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proceedings of the National Academy of Sciences of the United States of America. 2003, 100 (13): 7859-7864.
PubMed Central
CAS
PubMed
Google Scholar
Onsenal: EPAR summary for the public. [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000466/WC500044631.pdf]
Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, et al: Primary chemoprevention of familial adenomatous polyposis with sulindac. The New England journal of medicine. 2002, 346 (14): 1054-1059.
PubMed Central
CAS
PubMed
Google Scholar
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. The New England journal of medicine. 1993, 328 (18): 1313-1316.
CAS
PubMed
Google Scholar
Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK: Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. The British journal of surgery. 1993, 80 (12): 1618-1619.
CAS
PubMed
Google Scholar
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991, 101 (3): 635-639.
CAS
PubMed
Google Scholar
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, et al: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. The New England journal of medicine. 2000, 342 (26): 1946-1952.
CAS
PubMed
Google Scholar
Arber N, Eagle CJ, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, et al: Celecoxib for the prevention of colorectal adenomatous polyps. The New England journal of medicine. 2006, 355 (9): 885-895.
CAS
PubMed
Google Scholar
Iwama T, Akasu T, Utsunomiya J, Muto T: Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial. International journal of clinical oncology. 2006, 11 (2): 133-139.
CAS
PubMed
Google Scholar
Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, et al: Celecoxib for the prevention of sporadic colorectal adenomas. The New England journal of medicine. 2006, 355 (9): 873-884.
CAS
PubMed
Google Scholar
Arber N, Spicak J, Racz I, Zavoral M, Breazna A, Gerletti P, Lechuga MJ, Collins N, Rosenstein RB, Eagle CJ, et al: Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. The American journal of gastroenterology. 2011, 106 (6): 1135-1146.
PubMed
Google Scholar
Vaish V, Piplani H, Rana C, Sanyal SN: Angiostatic Properties of Sulindac and Celecoxib in the Experimentally Induced Inflammatory Colorectal Cancer. Cell biochemistry and biophysics. 2012
Google Scholar
Lee Y, Kim H, Kim W, Yoon JH, Jeong SH, Jung Y: Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis. Journal of drug targeting. 2012, 20 (6): 524-534.
CAS
PubMed
Google Scholar
Rayman MP: The use of high-selenium yeast to raise selenium status: how does it measure up?. The British journal of nutrition. 2004, 92 (4): 557-573.
CAS
PubMed
Google Scholar
Mehdi Y, Hornick JL, Istasse L, Dufrasne I: Selenium in the environment, metabolism and involvement in body functions. Molecules. 2013, 18 (3): 3292-3311.
CAS
PubMed
Google Scholar
Bera S, De Rosa V, Rachidi W, Diamond AM: Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention?. Mutagenesis. 2013, 28 (2): 127-134.
PubMed Central
CAS
PubMed
Google Scholar
Sanmartin C, Plano D, Sharma AK, Palop JA: Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. International journal of molecular sciences. 2012, 13 (8): 9649-9672.
PubMed Central
CAS
PubMed
Google Scholar
Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA : the journal of the American Medical Association. 1996, 276 (24): 1957-1963.
CAS
PubMed
Google Scholar
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA : the journal of the American Medical Association. 2009, 301 (1): 39-51.
CAS
PubMed
Google Scholar
You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, et al: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute. 2006, 98 (14): 974-983.
PubMed
Google Scholar
Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Estaquio C, Hercberg S: Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. International journal of cancer Journal international du cancer. 2005, 116 (2): 182-186.
CAS
PubMed
Google Scholar
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C: Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004, 364 (9441): 1219-1228.
CAS
PubMed
Google Scholar
Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR: Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. International journal of cancer Journal international du cancer. 2006, 118 (7): 1777-1781.
CAS
PubMed
Google Scholar
Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster CB, Schatzkin A, Hayes RB: High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006, 15 (2): 315-320.
CAS
Google Scholar
Bonelli L, Puntoni M, Gatteschi B, Massa P, Missale G, Munizzi F, Turbino L, Villanacci V, De Censi A, Bruzzi P: Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial. Journal of gastroenterology. 2012
Google Scholar
British National Formulary. [http://www.bnf.org]
Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nature reviews Molecular cell biology. 2000, 1 (1): 11-21.
CAS
PubMed
Google Scholar
Cruzalegui FH, Bading H: Calcium-regulated protein kinase cascades and their transcription factor targets. Cellular and molecular life sciences : CMLS. 2000, 57 (3): 402-410.
CAS
PubMed
Google Scholar
Lamprecht SA, Lipkin M: Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Annals of the New York Academy of Sciences. 2001, 952: 73-87.
CAS
PubMed
Google Scholar
Lipkin M: Preclinical and early human studies of calcium and colon cancer prevention. Annals of the New York Academy of Sciences. 1999, 889: 120-127.
CAS
PubMed
Google Scholar
Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, Cross HS: Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer detection and prevention. 2000, 24 (2): 127-136.
CAS
PubMed
Google Scholar
Kim KZ, Shin A, Kim J, Park JW, Park SC, Choi HS, Chang HJ, Kim DY, Oh JH: Association between CASR Polymorphisms, Calcium Intake, and Colorectal Cancer Risk. PloS one. 2013, 8 (3): e59628-
PubMed Central
CAS
PubMed
Google Scholar
Thomas MG, Thomson JP, Williamson RC: Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. The British journal of surgery. 1993, 80 (4): 499-501.
CAS
PubMed
Google Scholar
Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J: Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000, 356 (9238): 1300-1306.
CAS
PubMed
Google Scholar
Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, et al: Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. The New England journal of medicine. 1999, 340 (2): 101-107.
CAS
PubMed
Google Scholar
Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, Larsen S, Osnes M: Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion. 1998, 59 (2): 148-156.
CAS
PubMed
Google Scholar
Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM: Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer epidemiology. 2013, 37 (3): 278-283.
PubMed
Google Scholar
Bristow SM, Bolland MJ, Maclennan GS, Avenell A, Grey A, Gamble GD, Reid IR: Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. The British journal of nutrition. 2013, 1-10.
Google Scholar
Park SY, Murphy SP, Wilkens LR, Nomura AM, Henderson BE, Kolonel LN: Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. American journal of epidemiology. 2007, 165 (7): 784-793.
PubMed
Google Scholar
Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A: Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Archives of internal medicine. 2009, 169 (4): 391-401.
PubMed Central
CAS
PubMed
Google Scholar
Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, et al: Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. Journal of the National Cancer Institute. 2004, 96 (13): 1015-1022.
CAS
PubMed
Google Scholar
Huncharek M, Muscat J, Kupelnick B: Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutrition and cancer. 2009, 61 (1): 47-69.
CAS
PubMed
Google Scholar
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. The American journal of clinical nutrition. 2007, 85 (6): 1586-1591.
CAS
PubMed
Google Scholar
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. The New England journal of medicine. 2006, 354 (7): 684-696.
CAS
PubMed
Google Scholar
Flood A, Peters U, Chatterjee N, Lacey JV, Schairer C, Schatzkin A: Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005, 14 (1): 126-132.
CAS
Google Scholar
Scott JM: Folate and vitamin B12. The Proceedings of the Nutrition Society. 1999, 58 (2): 441-448.
CAS
PubMed
Google Scholar
World Health Organization (WHO): Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women. Geneva. 2012
Google Scholar
Duthie SJ: Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. Journal of inherited metabolic disease. 2011, 34 (1): 101-109.
CAS
PubMed
Google Scholar
Choi SW, Mason JB: Folate and carcinogenesis: an integrated scheme. The Journal of nutrition. 2000, 130 (2): 129-132.
CAS
PubMed
Google Scholar
Pufulete M, Abbadi RA, Arno M, Ewins M, Green C, Astarloa EA, Sanders T, Emery P: The influence of folate supplementation on global gene expression in normal colonic mucosa of subjects with colorectal adenoma. Molecular nutrition & food research. 2013, 57 (4): 709-720.
CAS
Google Scholar
Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER: Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. Journal of the National Cancer Institute. 1998, 90 (1): 57-62.
CAS
PubMed
Google Scholar
Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC: Folate, methionine, and alcohol intake and risk of colorectal adenoma. Journal of the National Cancer Institute. 1993, 85 (11): 875-884.
CAS
PubMed
Google Scholar
Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE: Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA : the journal of the American Medical Association. 2008, 300 (17): 2012-2021.
PubMed
Google Scholar
Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, Kucuk O, Levi E, Axelrod BN, Patel BB, Majumdar AP: Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World journal of gastroenterology : WJG. 2008, 14 (28): 4492-4498.
PubMed Central
CAS
PubMed
Google Scholar
Zhu S, Mason J, Shi Y, Hu Y, Li R, Wahg M, Zhou Y, Jin G, Xie Y, Wu G, et al: The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chinese medical journal. 2003, 116 (1): 15-19.
CAS
PubMed
Google Scholar
Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, et al: Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA : the journal of the American Medical Association. 2007, 297 (21): 2351-2359.
CAS
PubMed
Google Scholar
Qin X, Cui Y, Shen L, Sun N, Zhang Y, Li J, Xu X, Wang B, Huo Y, Wang X: Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. International journal of cancer Journal international du cancer. 2013
Google Scholar
Food and Agriculture Organization (FAO), World Health Organization (WHO): Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. (EN) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. 2001
Google Scholar
Geier MS, Butler RN, Howarth GS: Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. Cancer biology & therapy. 2006, 5 (10): 1265-1269.
CAS
Google Scholar
Ma EL, Choi YJ, Choi J, Pothoulakis C, Rhee SH, Im E: The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. International journal of cancer Journal international du cancer. 2010, 127 (4): 780-790.
PubMed Central
CAS
PubMed
Google Scholar
Wollowski I, Rechkemmer G, Pool-Zobel BL: Protective role of probiotics and prebiotics in colon cancer. The American journal of clinical nutrition. 2001, 73 (2 Suppl): 451S-455S.
CAS
PubMed
Google Scholar
Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al: Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. The American journal of clinical nutrition. 2007, 85 (2): 488-496.
CAS
PubMed
Google Scholar
Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, et al: A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. The American journal of clinical nutrition. 2009, 90 (3): 578-586.
CAS
PubMed
Google Scholar
Uccello M, Malaguarnera G, Basile F, D'Agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A: Potential role of probiotics on colorectal cancer prevention. BMC surgery. 2012, 12 (Suppl 1): S35-
PubMed Central
PubMed
Google Scholar
Grosso G, Bei R, Mistretta A, Marventano S, Calabrese G, Masuelli L, Giganti MG, Modesti A, Galvano F, Gazzolo D: Effects of Vitamin C on health: a review of evidence. Frontiers in bioscience. 2013, 18: 1017-29.
CAS
Google Scholar
Vitale DC, Piazza C, Melilli B, Drago F, Salomone S: Isoflavones: estrogenic activity, biological effect and bioavailability. European journal of drug metabolism and pharmacokinetics. 2013, 38 (1): 15-25.
CAS
PubMed
Google Scholar
Li Volti G, Salomone S, Sorrenti V, Mangiameli A, Urso V, Siarkos I, Galvano F, Salamone F: Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Cardiovascular diabetology. 2011, 10: 62-
PubMed Central
CAS
PubMed
Google Scholar
Grosso G, Galvano F, Mistretta A, Marventano S, Nolfo F, Calabrese G, Buscemi S, Drago F, Veronesi U, Scuderi A: Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxidative medicine and cellular longevity. 2013, 2013: 157240-
PubMed Central
PubMed
Google Scholar
Steiner M: Influence of vitamin E on platelet function in humans. Journal of the American College of Nutrition. 1991, 10 (5): 466-473.
CAS
PubMed
Google Scholar
Kulie T, Groff A, Redmer J, Hounshell J, Schrager S: Vitamin D: an evidence-based review. Journal of the American Board of Family Medicine : JABFM. 2009, 22 (6): 698-706.
PubMed
Google Scholar
Cranney A, Weiler HA, O'Donnell S, Puil L: Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. The American journal of clinical nutrition. 2008, 88 (2): 513S-519S.
CAS
PubMed
Google Scholar
Osborne JE, Hutchinson PE: Vitamin D and systemic cancer: is this relevant to malignant melanoma?. The British journal of dermatology. 2002, 147 (2): 197-213.
CAS
PubMed
Google Scholar
Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD, Haile RW, et al: A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. The New England journal of medicine. 1994, 331 (3): 141-147.
CAS
PubMed
Google Scholar
McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR: A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer research. 1988, 48 (16): 4701-4705.
CAS
PubMed
Google Scholar
Ponz de Leon M, Roncucci L: Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scandinavian journal of gastroenterology Supplement. 1997, 222: 72-75.
CAS
PubMed
Google Scholar
Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M, et al: Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Diseases of the colon and rectum. 1993, 36 (3): 227-234.
CAS
PubMed
Google Scholar
MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, Gratten H, Lambert J, Newland RC, Ngu M, Russell A, et al: Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. Journal of the National Cancer Institute. 1995, 87 (23): 1760-1766.
CAS
PubMed
Google Scholar
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C: Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008, CD004183-3
Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Buring JE, Manson JE: Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. Journal of the National Cancer Institute. 2009, 101 (1): 14-23.
PubMed Central
CAS
PubMed
Google Scholar
Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA : the journal of the American Medical Association. 2005, 294 (1): 56-65.
CAS
PubMed
Google Scholar
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, et al: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA : the journal of the American Medical Association. 2005, 293 (11): 1338-1347.
PubMed
Google Scholar
Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn GS, Valanis B, Williams JH: The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Journal of the National Cancer Institute. 2004, 96 (23): 1743-1750.
CAS
PubMed
Google Scholar
Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S: The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Archives of internal medicine. 2004, 164 (21): 2335-2342.
CAS
PubMed
Google Scholar
Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK: The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1999, 8 (6): 489-493.
CAS
Google Scholar
Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P: Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA : the journal of the American Medical Association. 2003, 290 (4): 476-485.
CAS
PubMed
Google Scholar
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slate EH, Fischbach LA, Marshall JR, Clark LC: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2002, 11 (7): 630-639.
CAS
Google Scholar
Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, et al: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. The New England journal of medicine. 1996, 334 (18): 1145-1149.
CAS
PubMed
Google Scholar